Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

  • This share is currently suspended. It was suspended at a price of 470.00

Share Price Information for Dunedin Ent.it. (DNE)

Share Price is delayed by 15 minutes
Get Live Data
470.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
DNE Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Ent.it. Share Chart

Interim Management Statement

16 May 2011 10:33

RNS Number : 6513G
Dunedin Enterprise Inv Trust PLC
16 May 2011
 

Dunedin Enterprise Investment Trust PLC (Company No SC52844) - Interim Management Statement

Dunedin Enterprise Investment Trust PLC ("Dunedin Enterprise") presents its Interim Management Statement for the quarter ended 31 March 2011. This is the Company's first interim management statement for the financial year to 31 December 2011, as required by the FSA Disclosure and Transparency Rule 4.3.

 

1. Investment Objective

 

Dunedin Enterprise specialises in the provision of private equity finance. Private equity is medium to long term finance provided in return for an equity stake in established, potentially high growth private companies. The Company's investment objective is to achieve substantial long term capital growth in its assets through capital gains from its investments.

 

2. Unaudited net asset value per share

 

The unaudited net asset value per share at 31 March 2011 was 509.2p. This represents an increase of 2.4% from the level at 31 December 2010.

 

3. Share price and discount

 

The share price rose by 3.7% from 300p to 311p in the quarter to 31 March 2011. This compares to a decrease in the FTSE Small Cap Index of 0.1% over the same period.

 

Based upon the net asset value per share of 509.2p, the discount of the share price to the net asset value per share has remained largely unchanged moving from 39.7% to 38.9% in the quarter. When cash is excluded from net assets then the discount increases to 50.1%.

 

The share price at the close of business on 13 May 2011 was 355p, which was 14.1% higher than at 31 March 2011. The share price of 355p represents a discount of 30.3% to the net asset value per share of 509.2p and when cash is excluded from net assets then the discount increases to 39.0%.

 

4. Balance Sheet

 

The balance sheet as at 31 March 2011 is noted below:-

 

 
£'m
Investments:-
 
Dunedin managed
86.7
Third party managed
15.1
Listed private equity
16.1
Legacy technology funds
1.8
 
119.7
Cash and near cash
34.3
Other assets/liabilities 
(0.3)
Total net assets
153.7
 
 
Net asset value per share (p)
509.2

  

5. Valuations

 

The portfolio of investments has been revalued at 31 March 2011. The increase in net asset value in the quarter can be attributed to:-

 

·; an increase in the value of European fund investments of £2.4m due to a combination at the portfolio company level of strong trading, de-gearing and a movement from cost to an earnings based valuation,

·; an increase in the value of the SWIP Private Equity Fund of Funds II PLC of £1.8m due to an increase in underlying fund values,

·; a reduction of £0.3m following the sale of the European listed investments, and

·; other movements of -£0.3m.

 

6. Commitments

 

As at 31 March 2011 the Company has outstanding capital commitments to limited partnership funds of £77.4m. In addition to cash and near cash balances of £34.3m at 31 March 2011 the Company has a listed private equity investment (SWIP) of £16.1m.

 

7. Outlook

 

The number of new business opportunities is encouraging, but the market remains very competitive.

 

 

For further information on Dunedin Enterprise please go to www.dunedin.com

 

ENDS

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGCGDUBXBBGBL
Date   Source Headline
21st Jun 202110:28 amRNSDirector/PDMR Shareholding
12th May 20212:42 pmRNSResult of AGM
12th May 202111:31 amRNS1st Quarter Results
4th May 20217:00 amRNSPreliminary unaudited net asset value at 31/3/21
16th Mar 20218:41 amRNSDirector/PDMR Shareholding
16th Mar 20218:41 amRNSDirector/PDMR Shareholding
16th Mar 20218:20 amRNSDirector/PDMR Shareholding
16th Mar 20218:19 amRNSDirector/PDMR Shareholding
16th Mar 20218:18 amRNSDirector/PDMR Shareholding
15th Mar 20217:00 amRNSAnnual Financial Report
26th Feb 20217:00 amRNSPortfolio Update
1st Feb 20217:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/20
20th Nov 20207:47 amRNSDirector/PDMR Shareholding
20th Nov 20207:46 amRNSDirector/PDMR Shareholding
20th Nov 20207:44 amRNSDirector/PDMR Shareholding
20th Nov 20207:43 amRNSDirector/PDMR Shareholding
20th Nov 20207:42 amRNSDirector/PDMR Shareholding
20th Nov 20207:41 amRNSDirector/PDMR Shareholding
20th Nov 20207:39 amRNSDirector/PDMR Shareholding
17th Nov 20202:26 pmRNSDirector/PDMR Shareholding
16th Nov 20207:00 amRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNS3rd Quarter Results
10th Nov 20207:00 amRNSResult of Tender Offer
4th Nov 20201:05 pmRNSResult of General Meeting
2nd Nov 20207:00 amRNSQ3 Preliminary NAV and Tender Offer Price
21st Oct 202011:40 amRNSHolding(s) in Company
12th Oct 20201:17 pmRNSTender Offer
21st Sep 20207:00 amRNSHalf-year Report
18th Aug 20207:00 amRNSPortfolio Update
3rd Aug 20207:00 amRNSPreliminary Unaudited Net Asset Value at 30/6/20
20th Jul 20207:00 amRNSAppointment of Corporate Broker
14th Jul 202012:07 pmRNSSecond Price Monitoring Extn
14th Jul 202012:02 pmRNSPrice Monitoring Extension
10th Jun 20203:52 pmRNSListing Rule 9.6.14
6th May 20202:36 pmRNS1st Quarter Results
6th May 20202:36 pmRNSResult of AGM
6th May 20202:22 pmRNSDirectorate Change
1st May 20207:00 amRNSPreliminary unaudited net asset value at 31/3/20
25th Mar 20207:00 amRNSAnnual Financial Report
23rd Mar 202012:39 pmRNSPortfolio Update
12th Mar 20202:25 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSHolding(s) in Company
25th Feb 20201:22 pmRNSHolding(s) in Company
3rd Feb 20207:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/19
25th Nov 20197:00 amRNSHolding(s) in Company
15th Nov 20197:00 amRNS3rd Quarter Results
5th Nov 20197:00 amRNSPreliminary unaudited net asset value at 30/9/19
7th Oct 201910:00 amRNSStatement re change of auditor
13th Sep 20197:00 amRNSHalf-year Report
1st Aug 20197:00 amRNSPreliminary Unaudited Net Asset Value at 30/6/19

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.